Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors

Bioorganic & Medicinal Chemistry
2013.0

Abstract

A series of 2,3-disubstituted pyridines were synthesized and evaluated for their PDE4 inhibitory activity. We successfully modified undesirable cyano group of initial lead compound 2 to 4-pyridyl group with improvement of in vitro efficacy and optimized the position of nitrogen atoms in pyridine moiety and alkylene linker. The most potent compound showed significant efficacy in animal models of asthma and inflammation.

Knowledge Graph

Similar Paper

Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma
Bioorganic & Medicinal Chemistry Letters 2002.0
Syntheses and evaluation of pyrido[2,3-d]pyrimidine-2,4-diones as PDE 4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Phosphodiesterase Type IV Inhibition. Structure-Activity Relationships of 1,3-Disubstituted Pyrrolidines
Journal of Medicinal Chemistry 1995.0
Synthesis and Biological Activity of Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors
Journal of Medicinal Chemistry 2010.0
Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and bioactivity of 3,5-dimethylpyrazole derivatives as potential PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties
Bioorganic & Medicinal Chemistry Letters 2000.0
Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2002.0